# Bracco

> Bracco is a VC fund in Milan backing Medical and Health Care. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Milan, Italy
- Total investments: 3
- Last investment: Oct 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bracco/
- Website: https://www.bracco.com
- Facebook: https://www.facebook.com/Bracco-105889186141114

Bracco is a VC fund in Milan focused on Medical and Health Care. Bracco specializes in diagnostic imaging for the healthcare sector.

## Contacts

5 contacts available for Bracco. Shizune tracks 6 team members at Bracco. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bracco?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Health Care | 2 | 67% |
| Pharmaceutical | 2 | 67% |
| Therapeutics | 1 | 33% |
| Manufacturing | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 33% |
| United Kingdom | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chris Clark | Senior Director Digital Operations | 0 | https://shizune.co/investors/profile/chris-clark-8 |
| Cornelia B. Reininger | Director, Medical Services, Planning and Management | 0 | https://shizune.co/investors/profile/cornelia-b-reininger |
| Diana Bracco | President and CEO; Founder, CEO & President | 0 | https://shizune.co/investors/profile/diana-bracco |
| Elio Bracco | Founder | 0 | https://shizune.co/investors/profile/elio-bracco |
| Kohei Endo | President & Representative Director | 0 | https://shizune.co/investors/profile/kohei-endo-f691 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Blue Earth Therapeutics | Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of next-generation targeted radiotherapeutics to treat cancer patients. It is a sister company of Blue Earth Diagnostics. | $76.5M | Series A | Oct 30, 2024 |  |
| Blue Earth Therapeutics | Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of next-generation targeted radiotherapeutics to treat cancer patients. It is a sister company of Blue Earth Diagnostics. | $76.5M | Series A | Oct 30, 2024 |  |
| Polarean | Polarean designs and manufactures equipment for the production of hyperpolarized xenon or helium gas. When used in conjunction with MRI, these gases offer a fundamentally new and non-invasive functional imaging platform. Current investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression andtherapeutic response. In addition, xenon gas exhibits solubility and signal properties that enable it to be imaged within other tissues and organs.The company is pursuing regulatory approval for clinical use and also sells its hyperpolarizes and related equipment to academic research institutions worldwide. In addition to providing academic researchers with this equipment and support, Polarean Imaging plc. offers access to the intellectual property that provides freedom-to-operate in this technology area.Polarean was founded in 2011 and is headquartered in Durham, NC, USA. | $12.6M | Post-IPO Equity | May 22, 2024 |  |

3 of 3 investments shown.

## Co-investors
- [PBM Capital Group](https://shizune.co/investors/profile/pbm-capital-group) — VC Fund, 2 deals together
- [Sands Capital Ventures](https://shizune.co/investors/profile/sands-capital-ventures) — VC Fund, 2 deals together
- [Soleus Capital](https://shizune.co/investors/profile/soleus-capital) — VC Fund, 2 deals together
- [Woodline Partners](https://shizune.co/investors/profile/woodline-partners) — VC Fund, 2 deals together
- [NUKEM Isotopes](https://shizune.co/investors/profile/nukem-isotopes) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Bracco invest in?

Bracco invests primarily in Medical, Health Care and Pharmaceutical startups, most often at Series A and Post-IPO Equity stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Bracco?

Public channels for Bracco include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bracco?

The team at Bracco includes Chris Clark (Senior Director Digital Operations), Cornelia B. Reininger (Director, Medical Services, Planning and Management) and Diana Bracco (President and CEO; Founder, CEO & President), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co